Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (3y) (2012 - 2026)
Vertex Pharmaceuticals (VRTX) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 7,794.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 6,993.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 530.00 |
| Dec 31, 2025 | -708.00 |
| Sep 30, 2025 | -971.00 |
| Jun 30, 2025 | -1,155.00 |
| Mar 31, 2025 | -2,688.00 |
| Dec 31, 2024 | -711.00 |
| Sep 30, 2024 | -1,288.00 |
| Jun 30, 2024 | -13,074.00 |
| Mar 31, 2024 | -914.00 |
| Dec 31, 2023 | -655.00 |
| Sep 30, 2023 | -190.00 |
| Jun 30, 2023 | -593.00 |
| Mar 31, 2023 | -1,473.00 |
| Dec 31, 2022 | -30,907.00 |
| Sep 30, 2022 | 3,781.00 |
| Jun 30, 2022 | 2,169.00 |
| Mar 31, 2022 | 1,738.00 |
| Dec 31, 2021 | 2,767.00 |
| Sep 30, 2021 | 2,693.00 |
| Jun 30, 2021 | -2,510.00 |